Hui Zhu1,2, Lang Ying3, Wei Tang1,2, Xiujiang Yang2,4, Bo Sun5,6. 1. Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China. 2. Department of Oncology, Shanghai Medical College, Fudan University, 270 DongAn Road, Shanghai, 200032, China. 3. Department of Orthopaedics, Yancheng Third People's Hospital, The Affiliated Yancheng Hospital of Southeast University Medical College, 75 JuChang Road, Yancheng, 224001, China. 4. Department of Endoscopy, Fudan University Shanghai Cancer Center, Shanghai, China. 5. Department of Oncology, Shanghai Medical College, Fudan University, 270 DongAn Road, Shanghai, 200032, China. gidrsunbo@126.com. 6. Department of Endoscopy, Fudan University Shanghai Cancer Center, Shanghai, China. gidrsunbo@126.com.
Abstract
PURPOSE: To identify whether the features of preoperative MDCT or EUS could predict the histopathological grading scheme of pancreatic neuroendocrine neoplasms (pNENs). METHODS: A total of 25 patients with pNENs were enrolled in the present study. The qualitative and quantitative variables were reviewed. The qualitative variables included location, contour, border, necrosis, intratumoral vessel, homogeneity, calcification, peripancreatic fat/vessel infiltration, pancreatic duct dilatation, mass within pancreas, lymphadenopathy and hepatic metastasis on MDCT and border, echogenicity, cystic/solid and blood flow on EUS. The quantitative variables included long diameter (LD), short diameter (SD), unenhanced mass attenuation (UMA), unenhanced pancreatic attenuation (UPA), arterial phase mass attenuation (APMA), arterial phase pancreatic attenuation (APPA), portal venous phase mass attenuation (PVPMA), portal venous phase pancreatic attenuation (PVPPA), arterial phase enhancement degree (APED) and portal venous phase enhancement degree (PVPED). In addition, sex and age were also evaluated. Histopathological classifications met the criterion of 2010 edition WHO Histopathological Classifications. Kruskal-Wallis test and Boruta algorithm were conducted. RESULTS: Lymphadenopathy and peripancreatic fat or vascular invasion foretold higher histopathological grading level while well-defined border on EUS image lower grading level. CONCLUSIONS: Lymphadenopathy, border on EUS image and peripancreatic fat or vascular invasion can predict the histopathological grading scheme of pNENs.
PURPOSE: To identify whether the features of preoperative MDCT or EUS could predict the histopathological grading scheme of pancreatic neuroendocrine neoplasms (pNENs). METHODS: A total of 25 patients with pNENs were enrolled in the present study. The qualitative and quantitative variables were reviewed. The qualitative variables included location, contour, border, necrosis, intratumoral vessel, homogeneity, calcification, peripancreatic fat/vessel infiltration, pancreatic duct dilatation, mass within pancreas, lymphadenopathy and hepatic metastasis on MDCT and border, echogenicity, cystic/solid and blood flow on EUS. The quantitative variables included long diameter (LD), short diameter (SD), unenhanced mass attenuation (UMA), unenhanced pancreatic attenuation (UPA), arterial phase mass attenuation (APMA), arterial phase pancreatic attenuation (APPA), portal venous phase mass attenuation (PVPMA), portal venous phase pancreatic attenuation (PVPPA), arterial phase enhancement degree (APED) and portal venous phase enhancement degree (PVPED). In addition, sex and age were also evaluated. Histopathological classifications met the criterion of 2010 edition WHO Histopathological Classifications. Kruskal-Wallis test and Boruta algorithm were conducted. RESULTS:Lymphadenopathy and peripancreatic fat or vascular invasion foretold higher histopathological grading level while well-defined border on EUS image lower grading level. CONCLUSIONS:Lymphadenopathy, border on EUS image and peripancreatic fat or vascular invasion can predict the histopathological grading scheme of pNENs.
Authors: Massimo Falconi; Detlef Klaus Bartsch; Barbro Eriksson; Günter Klöppel; José M Lopes; Juan M O'Connor; Ramón Salazar; Babs G Taal; Marie Pierre Vullierme; Dermot O'Toole Journal: Neuroendocrinology Date: 2012-02-15 Impact factor: 4.914
Authors: Paul D James; Apostolos V Tsolakis; Mei Zhang; Paul J Belletrutti; Rachid Mohamed; Derek J Roberts; Steven J Heitman Journal: Gastrointest Endosc Date: 2015-04 Impact factor: 9.427
Authors: Shireen A Pais; Mohammad Al-Haddad; Mehdi Mohamadnejad; Julia K Leblanc; Stuart Sherman; Lee McHenry; John M DeWitt Journal: Gastrointest Endosc Date: 2010-03-20 Impact factor: 9.427
Authors: Anna Gallotti; Rocio Perez Johnston; Pietro A Bonaffini; Thun Ingkakul; Vikram Deshpande; Carlos Fernández-del Castillo; Dushyant V Sahani Journal: AJR Am J Roentgenol Date: 2013-02 Impact factor: 3.959